ITZIAR
VERGARA MICHELTORENA
Hospital de Cruces
Barakaldo, EspañaPublications in collaboration with researchers from Hospital de Cruces (4)
2022
-
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340
2020
-
The urinary transcriptome as a source of biomarkers for prostate cancer
Cancers, Vol. 12, Núm. 2
2010
-
Breast and ovarian cancer risk evaluation in families with a disease-causing mutation in BRCA1/2
Journal of Community Genetics, Vol. 1, Núm. 2, pp. 91-99
2008
-
Is integration of healthy lifestyle promotion into primary care feasible? Discussion and consensus sessions between clinicians and researchers
BMC Health Services Research, Vol. 8